Key statistics
As of last trade, Microbot Medical Inc (MBOT:NAQ) traded at 2.52, 101.48% above the 52 week low of 1.25 set on Mar 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.40 |
|---|---|
| High | 2.52 |
| Low | 2.34 |
| Bid | 2.51 |
| Offer | 2.52 |
| Previous close | 2.39 |
| Average volume | 2.48m |
|---|---|
| Shares outstanding | 67.16m |
| Free float | 67.16m |
| P/E (TTM) | -- |
| Market cap | 160.51m USD |
| EPS (TTM) | -0.4513 USD |
Data delayed at least 15 minutes, as of Mar 04 2026 17:56 GMT.
More ▼
- Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation
- Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event
- Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System
- Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
- Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
- Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption
- Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones
- Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
- Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
- Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
More ▼
